Published in Diabetologia on May 23, 2006
Ablation of CD11c-positive cells normalizes insulin sensitivity in obese insulin resistant animals. Cell Metab (2008) 5.10
Pioglitazone attenuates prostatic enlargement in diet-induced insulin-resistant rats by altering lipid distribution and hyperinsulinaemia. Br J Pharmacol (2010) 1.49
Nuclear factor erythroid 2-related factor 2 deletion impairs glucose tolerance and exacerbates hyperglycemia in type 1 diabetic mice. J Pharmacol Exp Ther (2010) 1.21
Impact of postprandial glycaemia on health and prevention of disease. Obes Rev (2012) 1.17
Cardiometabolic aspects of the polycystic ovary syndrome. Endocr Rev (2012) 1.05
JNKs, insulin resistance and inflammation: A possible link between NAFLD and coronary artery disease. World J Gastroenterol (2011) 1.05
Integrative genomic analysis of CREB defines a critical role for transcription factor networks in mediating the fed/fasted switch in liver. BMC Genomics (2013) 0.97
Methionine deficiency and hepatic injury in a dietary steatohepatitis model. Dig Dis Sci (2007) 0.97
ER stress and hepatic lipid metabolism. Front Genet (2014) 0.92
Liver clock protein BMAL1 promotes de novo lipogenesis through insulin-mTORC2-AKT signaling. J Biol Chem (2014) 0.88
Hepatic steatosis in type 1 diabetes. Rev Diabet Stud (2012) 0.87
Forkhead box transcription factor regulation and lipid accumulation by hepatitis C virus. J Virol (2014) 0.85
Quantifying the improvement of surrogate indices of hepatic insulin resistance using complex measurement techniques. PLoS One (2012) 0.83
Chronic alcohol consumption potentiates the development of diabetes through pancreatic β-cell dysfunction. World J Biol Chem (2015) 0.81
MicroRNA-185 regulates expression of lipid metabolism genes and improves insulin sensitivity in mice with non-alcoholic fatty liver disease. World J Gastroenterol (2014) 0.81
Antidiabetic properties of dietary flavonoids: a cellular mechanism review. Nutr Metab (Lond) (2015) 0.80
Alloxan-induced diabetes causes morphological and ultrastructural changes in rat liver that resemble the natural history of chronic fatty liver disease in humans. J Diabetes Res (2015) 0.78
Loss of Hepatic CEACAM1: A Unifying Mechanism Linking Insulin Resistance to Obesity and Non-Alcoholic Fatty Liver Disease. Front Endocrinol (Lausanne) (2017) 0.77
Potential Bioactive Compounds from Seaweed for Diabetes Management. Mar Drugs (2015) 0.77
Responses in gut microbiota and fat metabolism to a halogenated methane analogue in Sprague Dawley rats. Microb Biotechnol (2015) 0.76
Fructose only in pregnancy provokes hyperinsulinemia, hypoadiponectinemia, and impaired insulin signaling in adult male, but not female, progeny. Eur J Nutr (2015) 0.76
Nonmedicinal interventions in nonalcoholic fatty liver disease. Can J Gastroenterol Hepatol (2015) 0.75
Comment on: Weickert MO, Pfeiffer AFH (2006) Signalling mechanisms linking hepatic glucose and lipid metabolism. Diabetologia 49:1732-1741. Diabetologia (2006) 0.75
Rhodiola crenulata extract regulates hepatic glycogen and lipid metabolism via activation of the AMPK pathway. BMC Complement Altern Med (2016) 0.75
A dietary pattern protective against type 2 diabetes in the European Prospective Investigation into Cancer and Nutrition (EPIC)--Potsdam Study cohort. Diabetologia (2005) 1.79
Glucose inhibits the insulin-induced activation of the insulin-degrading enzyme in HepG2 cells. Diabetologia (2009) 1.55
Continuous glucose monitoring in people with diabetes: the randomized controlled Glucose Level Awareness in Diabetes Study (GLADIS). Diabet Med (2015) 1.18
Impairment of fat oxidation under high- vs. low-glycemic index diet occurs before the development of an obese phenotype. Am J Physiol Endocrinol Metab (2009) 1.18
Euglycemic hyperinsulinemia, but not lipid infusion, decreases circulating ghrelin levels in humans. J Endocrinol Invest (2002) 1.17
Endogenous and exogenous glucocorticoids decrease plasma ghrelin in humans. Eur J Endocrinol (2004) 1.16
Impact of cereal fibre on glucose-regulating factors. Diabetologia (2005) 1.15
Effect of human body weight changes on circulating levels of peptide YY and peptide YY3-36. J Clin Endocrinol Metab (2006) 1.13
Microalbuminuria is a major determinant of elevated plasma retinol-binding protein 4 in type 2 diabetic patients. Kidney Int (2007) 1.09
Effects of marked weight loss on plasma levels of adiponectin, markers of chronic subclinical inflammation and insulin resistance in morbidly obese women. Int J Obes (Lond) (2005) 1.08
Insulin decreases human adiponectin plasma levels. Horm Metab Res (2003) 1.05
Elevated hepatic chemerin mRNA expression in human non-alcoholic fatty liver disease. Eur J Endocrinol (2013) 0.99
Elevation of blood glucose following anaesthetic treatment in C57BL/6 mice. Horm Metab Res (2004) 0.97
Glucagon increases circulating fibroblast growth factor 21 independently of endogenous insulin levels: a novel mechanism of glucagon-stimulated lipolysis? Diabetologia (2012) 0.94
Initial weight loss on an 800-kcal diet as a predictor of weight loss success after 8 weeks: the Diogenes study. Eur J Clin Nutr (2010) 0.93
Fatty acid composition of adipose tissue triglycerides after weight loss and weight maintenance: the DIOGENES study. Physiol Res (2012) 0.89
Intravenous lipid and heparin infusion-induced elevation in free fatty acids and triglycerides modifies circulating androgen levels in women: a randomized, controlled trial. J Clin Endocrinol Metab (2008) 0.88
Arabinoxylan-enriched meal increases serum ghrelin levels in healthy humans. Horm Metab Res (2005) 0.88
Improved insulin sensitivity, preserved beta cell function and improved whole-body glucose metabolism after low-dose growth hormone replacement therapy in adults with severe growth hormone deficiency: a pilot study. Diabetologia (2010) 0.88
Identification of an intracellular metabolic signature impairing beta cell function in the rat beta cell line INS-1E and human islets. Diabetologia (2011) 0.86
Free fatty acids increase androgen precursors in vivo. J Clin Endocrinol Metab (2006) 0.86
Circulating ACE is a predictor of weight loss maintenance not only in overweight and obese women, but also in men. Int J Obes (Lond) (2012) 0.86
Leptin and endocrine parameters in marathon runners. Int J Sports Med (2012) 0.84
Adiponectin oligomers in human serum during acute and chronic exercise: relation to lipid metabolism and insulin sensitivity. Int J Sports Med (2006) 0.83
Post-prandial decrease of human plasma ghrelin in the absence of insulin. J Endocrinol Invest (2003) 0.82
Short-term therapy with atorvastatin or fenofibrate does not affect plasma ghrelin, resistin or adiponectin levels in type 2 diabetic patients with mixed hyperlipoproteinaemia. Acta Diabetol (2007) 0.81
Glucagon inhibits ghrelin secretion in humans. Eur J Endocrinol (2005) 0.81
Ca2+/calmodulin-dependent protein kinase II delta2 regulates gene expression of insulin in INS-1 rat insulinoma cells. Cell Calcium (2003) 0.80
Increase in adiponectin levels during pioglitazone therapy in relation to glucose control, insulin resistance as well as ghrelin and resistin levels. J Endocrinol Invest (2006) 0.80
Glucagon suppression of ghrelin secretion is exerted at hypothalamus-pituitary level. J Clin Endocrinol Metab (2006) 0.80
Effects of hyperlipidaemia on glucocorticoid metabolism: results of a randomized controlled trial in healthy young women. Clin Endocrinol (Oxf) (2011) 0.79
Experience and acceptability of diets of varying protein content and glycemic index in an obese cohort: results from the Diogenes trial. Eur J Clin Nutr (2013) 0.79
Enhancement of early- and late-phase insulin secretion and insulin sensitivity by the combination of repaglinide and metformin in type 2 diabetes mellitus. Exp Clin Endocrinol Diabetes (2004) 0.78
Effects of euglycemic hyperinsulinemia and lipid infusion on circulating cholecystokinin. J Clin Endocrinol Metab (2008) 0.78
Alterations of pancreatic beta-cell mass and islet number due to Ins2-controlled expression of Cre recombinase: RIP-Cre revisited; part 2. Horm Metab Res (2007) 0.78
Effect of immunosuppressive and other drugs on the cortisol-cortisone shuttle in human kidney and liver. Horm Metab Res (2007) 0.77
Acarbose treatment enhances mid-regional pro-atrial natriuretic peptide concentrations in non-diabetic individuals: further evidence for a common cardiometabolic pathway? Diabetologia (2012) 0.77
Chemical inhibition of citrate metabolism alters glucose metabolism in mice. Horm Metab Res (2006) 0.77
Adaptation of the hypothalamic-pituitary hormones during intensive endurance training. Clin Endocrinol (Oxf) (2005) 0.77
Predicting impaired glucose metabolism in women with polycystic ovary syndrome by decision tree modelling. Diabetologia (2006) 0.77
[Preventing type 2 diabetes: what does dietary fiber achieve?]. MMW Fortschr Med (2005) 0.77
Levothyroxine medication is associated with adiposity independent of TSH. Exp Clin Endocrinol Diabetes (2012) 0.77
The impact of insulin-independent, glucagon-induced suppression of total ghrelin on satiety in obesity and type 1 diabetes mellitus. J Clin Endocrinol Metab (2013) 0.76
Chemical inhibition of citrate metabolism alters body fat content in mice. Horm Metab Res (2006) 0.76
Ghrelin is not suppressed in hyperglycemic clamps by gastric inhibitory polypeptide and arginine. Regul Pept (2005) 0.76
To: Lindner T, Cockburn BN, Bell GI (1999). Molecular genetics of MODY in Germany. Diabetologia 42: 121-123. Diabetologia (2002) 0.76
Predictors of weight loss maintenance and attrition during a 6-month dietary intervention period: results from the DiOGenes study. Clin Obes (2011) 0.76
T3/rT3-ratio is associated with insulin resistance independent of TSH. Horm Metab Res (2010) 0.76
Function of human mineralocorticoid receptor splice variant. Eur J Endocrinol (2004) 0.75
Metabolism of synthetic steroids by the human placenta. Placenta (2006) 0.75
In vivo activity of 11beta-hydroxysteroid dehydrogenase type 1 and free fatty acid-induced insulin resistance. Clin Endocrinol (Oxf) (2005) 0.75
Comparison of oral glucose tolerance test (OGTT) 100 g with OGTT 75 g for evaluation of acromegalic patients and the impact of gender on test reproducibility. Clin Endocrinol (Oxf) (2011) 0.75
Serum resistin increases in a postprandial state during liquid meal challenge test in healthy human subjects. J Endocrinol Invest (2006) 0.75
[Hormone replacement therapy. What is reliable?]. Internist (Berl) (2003) 0.75
Effects of the putatively oncogenic protein kinase Calpha D294G mutation on enzymatic activity and cell growth and its occurrence in human thyroid neoplasias. Horm Metab Res (2002) 0.75
The application of good clinical practice in nutrition research. Eur J Clin Nutr (2012) 0.75
Annual change in insulin sensitivity. Horm Metab Res (2011) 0.75